Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Burden

Showing results (81-90 of 112) with videos related to

Pageof 12
Sort By:
Genes and Immunity|July 10, 2009
Differential contribution of CDKAL1 variants to psoriasis, Crohn's disease and type II diabetesM Quaranta, A D Burden, C E M Griffiths, et al.
The British Journal of Dermatology|June 14, 2005
Functional MASP2 single nucleotide polymorphism plays no role in psoriasisC Stover, S Barrett, N J Lynch, et al.
The Journal of Pathology|January 29, 2008
Gadodiamide contrast agent 'activates' fibroblasts: a possible cause of nephrogenic systemic fibrosisM Edward, J A Quinn, S Mukherjee, et al.
Journal of Medical Genetics|June 3, 2004
Genetic analysis of PSORS2 markers in a UK dataset supports the association between RAPTOR SNPs and familial psoriasisF Capon, C Helms, C D Veal, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 7, 2017
European consensus statement on phenotypes of pustular psoriasisA A Navarini, A D Burden, F Capon, et al.
Experimental Dermatology|May 4, 2023
Efficacy of spesolimab for the treatment of generalized pustular psoriasis flares across pre-specified patient subgroups in the Effisayil 1 studyA D Burden, Y Okubo, M Zheng, et al.
The British Journal of Dermatology|February 24, 2012
The British Association of Dermatologists' Biologic Interventions Register (BADBIR): design, methodology and objectivesA D Burden, R B Warren, C E Kleyn, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|October 22, 2019
Risk of major cardiovascular events in patients with psoriasis receiving biologic therapies: a prospective cohort studyW Rungapiromnan, K J Mason, M Lunt, et al.
Journal of Medical Genetics|June 17, 2003
Haplotype analysis of distantly related populations implicates corneodesmosin in psoriasis susceptibilityF Capon, I K Toal, J C Evans, et al.
The British Journal of Dermatology|April 8, 2017
Identification of factors that may influence the selection of first-line biological therapy for people with psoriasis: a prospective, multicentre cohort studyN J Davison, R B Warren, K J Mason, et al.
Pageof 12

Showing results (81-90 of 112) with videos related to

Sort By:
Pageof 12
Genes and Immunity|July 10, 2009
Differential contribution of CDKAL1 variants to psoriasis, Crohn's disease and type II diabetesM Quaranta, A D Burden, C E M Griffiths, et al.
The British Journal of Dermatology|June 14, 2005
Functional MASP2 single nucleotide polymorphism plays no role in psoriasisC Stover, S Barrett, N J Lynch, et al.
The Journal of Pathology|January 29, 2008
Gadodiamide contrast agent 'activates' fibroblasts: a possible cause of nephrogenic systemic fibrosisM Edward, J A Quinn, S Mukherjee, et al.
Journal of Medical Genetics|June 3, 2004
Genetic analysis of PSORS2 markers in a UK dataset supports the association between RAPTOR SNPs and familial psoriasisF Capon, C Helms, C D Veal, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 7, 2017
European consensus statement on phenotypes of pustular psoriasisA A Navarini, A D Burden, F Capon, et al.
Experimental Dermatology|May 4, 2023
Efficacy of spesolimab for the treatment of generalized pustular psoriasis flares across pre-specified patient subgroups in the Effisayil 1 studyA D Burden, Y Okubo, M Zheng, et al.
The British Journal of Dermatology|February 24, 2012
The British Association of Dermatologists' Biologic Interventions Register (BADBIR): design, methodology and objectivesA D Burden, R B Warren, C E Kleyn, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|October 22, 2019
Risk of major cardiovascular events in patients with psoriasis receiving biologic therapies: a prospective cohort studyW Rungapiromnan, K J Mason, M Lunt, et al.
Journal of Medical Genetics|June 17, 2003
Haplotype analysis of distantly related populations implicates corneodesmosin in psoriasis susceptibilityF Capon, I K Toal, J C Evans, et al.
The British Journal of Dermatology|April 8, 2017
Identification of factors that may influence the selection of first-line biological therapy for people with psoriasis: a prospective, multicentre cohort studyN J Davison, R B Warren, K J Mason, et al.
Pageof 12